Literature DB >> 25120997

Comparative efficacy of two different dosages of intrathecal magnesium sulphate supplementation in subarachnoid block.

Binesh Kathuria1, Neeru Luthra2, Aanchal Gupta3, Anju Grewal4, Dinesh Sood4.   

Abstract

BACKGROUND: Spinal anaesthesia is the primary anaesthetic technique for many types of surgeries. Adjuncts to the local anaesthetics (LA) used in spinal anaesthesia can exhibit undesirable side-effects like respiratory depression, urinary retention, pruritis, haemodynamic instability and nausea and vomiting, limiting their use. Magnesium when used in therapeutic doses avoids all of these side-effects.
MATERIALS AND METHODS: We conducted a randomized double blind study on 90 patients, 30 in each group, scheduled for orthopaedic lower limb surgery under subarachnoid block. Group I: received bupivacaine (0.5%), 12.5 mg + 0.5 ml of preservative free 0.9% normal saline, Group II received bupivacaine (0.5%), 12.5 mg + 0.2 ml (50 mg) of preservative free 25 % magnesium sulphate + 0.3 ml of preservative free 0.9% normal saline Group III: received bupivacaine (0.5%) 12.5 mg + 0.3 ml (75 mg) of 25 % magnesium sulphate + 0.2 ml of preservative free 0.9% normal saline for subarachnoid block. The onset and duration of sensory block, the highest dermatomal level of sensory block, motor block, time to complete motor block recovery and duration of spinal anaesthesia were recorded. STATISTICAL ANALYSIS: ANOVA was applied to determine the significance of difference between different groups. If p-value was significant then Turkey's Post Hoc Multicomparison test was applied. Values of p<0.05 were considered to be statistically significant.
RESULTS: The time of maximum sensory block, time of onset of motor block, duration of sensory block, duration of motor block and time of analgesia request were prolonged in patients given magnesium 50mg and 75mg along with local anaesthetic intrathecally.
CONCLUSION: N-methyl-D-aspartate (NMDA) receptor antagonist, magnesium when administered intrathecally along with local anaesthetics prolongs the duration of spinal analgesia without adverse effects.

Entities:  

Keywords:  Anaesthesia duration; Local anaesthetic; Magnesium; Opioid; Spinal

Year:  2014        PMID: 25120997      PMCID: PMC4129284          DOI: 10.7860/JCDR/2014/8295.4510

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  25 in total

1.  A randomised study of magnesium sulphate as an adjuvant to intrathecal bupivacaine in patients with mild preeclampsia undergoing caesarean section.

Authors:  S Malleeswaran; N Panda; P Mathew; R Bagga
Journal:  Int J Obstet Anesth       Date:  2010-02-18       Impact factor: 2.603

Review 2.  Preemptive analgesia--treating postoperative pain by preventing the establishment of central sensitization.

Authors:  C J Woolf; M S Chong
Journal:  Anesth Analg       Date:  1993-08       Impact factor: 5.108

3.  Inadvertant intrathecal administration of magnesium sulfate.

Authors:  M J Lejuste
Journal:  S Afr Med J       Date:  1985-09-14

4.  Comparison of postoperative analgesic effect of intrathecal magnesium and fentanyl added to bupivacaine in patients undergoing lower limb orthopedic surgery.

Authors:  Marzieh-Beigom Khezri; Siamak Yaghobi; Mahsa Hajikhani; Saeid Asefzadeh
Journal:  Acta Anaesthesiol Taiwan       Date:  2012-03-31

5.  Neurotoxicity after spinal anaesthesia induced by serial intrathecal injections of magnesium sulphate. An experimental study in a rat model.

Authors:  M Chanimov; M L Cohen; Y Grinspun; M Herbert; R Reif; I Kaufman; M Bahar
Journal:  Anaesthesia       Date:  1997-03       Impact factor: 6.955

Review 6.  Effect of intrathecal magnesium in the presence or absence of local anaesthetic with and without lipophilic opioids: a systematic review and meta-analysis.

Authors:  A P Morrison; J M Hunter; S H Halpern; A Banerjee
Journal:  Br J Anaesth       Date:  2013-03-26       Impact factor: 9.166

Review 7.  Magnesium sulfate therapy in preeclampsia and eclampsia.

Authors:  A G Witlin; B M Sibai
Journal:  Obstet Gynecol       Date:  1998-11       Impact factor: 7.661

Review 8.  The use of intrathecal midazolam in humans: a case study of process.

Authors:  Tony L Yaksh; Jeffrey W Allen
Journal:  Anesth Analg       Date:  2004-06       Impact factor: 5.108

9.  Comparative study of intrathecal dexmedetomidine with intrathecal magnesium sulfate used as adjuvants to bupivacaine.

Authors:  Deepika Shukla; Anil Verma; Apurva Agarwal; H D Pandey; Chitra Tyagi
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-10

10.  Adding different doses of intrathecal magnesium sulfate for spinal anesthesia in the cesarean section: A prospective double blind randomized trial.

Authors:  Mitra Jabalameli; Seyed Hamid Pakzadmoghadam
Journal:  Adv Biomed Res       Date:  2012-05-11
View more
  3 in total

1.  Intrathecal magnesium sulfate as a spinal adjuvant in two different doses, combined with 0.5% heavy bupivacaine for infraumbilical surgeries.

Authors:  Monu Yadav; P Bhanu Kumar; Madhavi Singh; Ramachandran Gopinath
Journal:  Anesth Essays Res       Date:  2015 Sep-Dec

2.  Intrathecal magnesium sulfate does not reduce the ED50 of intrathecal hyperbaric bupivacaine for cesarean delivery in healthy parturients: a prospective, double blinded, randomized dose-response trial using the sequential allocation method.

Authors:  Fei Xiao; Wenping Xu; Ying Feng; Feng Fu; Xiaomin Zhang; Yinfa Zhang; Lizhong Wang; Xinzhong Chen
Journal:  BMC Anesthesiol       Date:  2017-01-17       Impact factor: 2.217

Review 3.  Magnesium and Pain.

Authors:  Hyun-Jung Shin; Hyo-Seok Na; Sang-Hwan Do
Journal:  Nutrients       Date:  2020-07-23       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.